Childhood ovarian cancers. new advances in treatment
Piver, M.S.; Lurain, J.
New York State Journal of Medicine 79(8): 1196-1199
1979
ISSN/ISBN: 0028-7628 PMID: 223094 Document Number: 139755
Document emailed within 1 workday
Related Documents
Bian, M.L.; Lang, J.H. 1994: Advances in the genetic research on ovarian cancers Zhonghua Fu Chan Ke Za Zhi 29(3): 181-183Maassen, V.; Debus-Thiede, G. 1994: Ovarian cancers and simultaneous primary cancers of the upper female genital tract Zentralblatt für Gynakologie 116(9): 527-530
Balwierz, W.; Pawińska, K.; Skoczeń, S.; Klekawka, T.; Strojny, W.; Niezgoda, A. 2004: Perspectives in the use of imatinib in the treatment of childhood cancers Przeglad lekarski 61 Suppl. 2: 95-99
Espié, M.; Cuvier, C.; Gorins, A.; Marty, M. 1998: Taxanes in the treatment of breast and ovarian cancers: current indications and results Contraception Fertilite Sexualite 26(11): 805-811
Simon, G.; Brunet, R.; Chauvergne, J. 1971: Palliative treatment of ovarian cancers with the association of thiotepa and of 5-fluoro-uracil Bordeaux Medical 4(5): 1523-1530
Daum, R. 1977: Advances in the treatment of malignant tumors in childhood: Wilm's tumor as an example Münchener Medizinische Wochenschrift 119(18): 629-632
Wang, P.H.; Chang, C. 2004: Androgens and ovarian cancers European Journal of Gynaecological Oncology 25(2): 157-163
Plummer, R.; Plummer, R. 2015: PARP inhibitors in ovarian and other cancers Clinical Advances in Hematology and Oncology: H&o 13(5): 285-287
Giuntoli, R.L.; Rodriguez, G.C.; Whitaker, R.S.; Dodge, R.; Voynow, J.A. 1998: Mucin gene expression in ovarian cancers Cancer Research 58(23): 5546-5550
Chudecka-Głaz, A.; Rzepka-Górska, I.; Kośmider, M. 2002: Age at diagnosis and other prognosticators in epithelial ovarian cancers International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 78(1): 65-67
Forget, P.; Dresse, M.F.; Schmitz, V.; Hoyoux, C. 2006: Secondary cancers in childhood Revue Medicale de Liege 61(2): 76-80
Bernaudin, J.F.; Atassi, K.; Lancret, P.; Pinchon, M.C.; Bignon, J. 1981: Recent advances in methods for morphological study of pleuro-pulmonary diseases (excluding bronchial cancers) La Revue du Praticien 31(1): 21-26
Picaud, A.; Walter, P.; Minko Mi Etoua, D.; Faye, A.; N'Sounda, C.; Nlome Nze, A.R.; Lunven, B. 1992: Stage IIi and IV epithelial ovarian cancers. Therapeutic problems Revue Francaise de Gynecologie et d'Obstetrique 87(1): 1-6
Posawetz, W.; Jakse, R.; Petru, E.; Pickel, H.; Heydarfadai, M. 1990: Scalenus biopsy in diagnosis of ovarian and uterine cancers Hno 38(10): 367-369
Patte, C.; Dufour, C. 2007: Good prognosis childhood cancers La Revue du Praticien 57(10): 1070-1076
Arora, B.; Kurkure, P.; Parikh, P. 2005: Childhood cancers: perspectives in India Journal of the Indian Medical Association 103(9): 479-482
Kawagoe, K.; Kawana, T.; Mizuno, M. 1989: A clinicopathological study of advanced ovarian cancers without an enlargement of the ovaries Gan no Rinsho. Japan Journal of Cancer Clinics 35(1): 46-50
Lassmann, S.; Shen, Y.; Jütting, U.; Whiele, P.; Walch, A.; Gitsch, G.; Hasenburg, A.; Werner, M. 2007: Aurora-a is a predictive marker for stage IIi epithelial ovarian cancers Verhandlungen der Deutschen Gesellschaft für Pathologie 91: 225-232
Lorimier, G.; Reigner, B.; Rive, C.; Cronier, P.; Talha, A.; Guntz, M. 1988: Ovarian metastases of digestive cancers. Diagnostic and therapeutic management Journal de Chirurgie 125(12): 699-703
Kern, D.H. 1998: Heterogeneity of drug resistance in human breast and ovarian cancers Cancer Journal From Scientific American 4(1): 41-45